Full expression of cardiomyopathy is partly dependent on B‐cells: a pathway that involves cytokine activation, immunoglobulin deposition, and activation of apoptosis

AM Cordero‐Reyes, KA Youker… - Journal of the …, 2016 - Am Heart Assoc
Background Limited information exists on the role of B‐cell‐dependent mechanisms in the
progression of heart failure (HF). However, in failing human myocardium, there is evidence …

IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus …

M Rahman, S Sing, Z Golabkesh, R Fiskesund… - Clinical …, 2016 - Elsevier
Objectives Phosphorylcholine (PC) and malondialdehyde (MDA) are generated during lipid
peroxidation and form adducts with proteins as albumin as studied herein. Atherosclerosis …

Atherosclerotic plaque vulnerability in the statin era

J Nilsson - European Heart Journal, 2017 - academic.oup.com
Life style changes and improved medical therapy have decreased cardiovascular mortality
in many countries over the last decades. This has been accompanied by changes in disease …

The effects of diet-induced obesity on B cell function

SR Shaikh, KM Haas, MA Beck… - Clinical & Experimental …, 2015 - academic.oup.com
Summary B-1 and B-2 B cell subsets carry out a diverse array of functions that range broadly
from responding to innate stimuli, antigen presentation, cytokine secretion and antibody …

[HTML][HTML] Duality of B cell-CXCL13 axis in tumor immunology

AJ Rubio, T Porter, X Zhong - Frontiers in Immunology, 2020 - frontiersin.org
Tumor immunity is a rapidly evolving area of research consisting of many possible
permutations of immune cell tumor interactions that are dependent upon cell type, tumor …

[HTML][HTML] B cell and CD4 T cell interactions promote development of atherosclerosis

C Tay, P Kanellakis, H Hosseini, A Cao… - Frontiers in …, 2020 - frontiersin.org
Interaction between B and CD4 T cells is crucial for their optimal responses in adaptive
immunity. Immune responses augmented by their partnership promote chronic inflammation …

[HTML][HTML] Advances in immunotherapy modalities for atherosclerosis

Q Meng, H Liu, J Liu, Y Pang, Q Liu - Frontiers in Pharmacology, 2023 - frontiersin.org
Cardiovascular disease (CVD) is one of the leading causes of death worldwide.
Atherosclerosis is the pathological basis of atherosclerotic cardiovascular disease (ASCVD) …

Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis

M Lacy, D Atzler, R Liu, M De Winther, C Weber… - Pharmacology & …, 2019 - Elsevier
Cardiovascular disease (CVD) continues to be a leading cause of death worldwide with
atherosclerosis being the major underlying pathology. The interplay between lipids and …

[HTML][HTML] Effect of anti-rheumatic drugs on cardiovascular disease events in rheumatoid arthritis

Y Baoqi, M Dan, Z Xingxing, Z Xueqing… - Frontiers in …, 2022 - frontiersin.org
Rheumatoid arthritis (RA) is an autoimmune disease with erosive arthritis as its main
manifestation, which can involve multiple systems. RA patients may have a variety of …

[HTML][HTML] Atherosclerosis from Newborn to Adult—Epidemiology, Pathological Aspects, and Risk Factors

AC Luca, SG David, AG David, V Țarcă, IA Pădureț… - Life, 2023 - mdpi.com
Cardiovascular disease is the leading cause of mortality and morbidity throughout the world,
accounting for 16.7 million deaths each year. The underlying pathological process for the …